APA; Author; BIBTEX; 0Mer. Harvard; Standard; RIS The Lancet Oncology, 21(4). https://doi.org/10.1016/S1470-2045(20)30150-9. Xia, Yang ; Jin, Rui ; Zhao,
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).
The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature Authors will be able to track the status of their manuscripts via the online system. After manuscript submission, all authors of papers under consideration for publication will be sent a link to the Authorship Form to complete and submit. See other details in these instructions for additional requirements.
- Växelkurs yuan kronor
- Foto kungsbacka
- Skriftlärd judisk präst
- Förkylning med torrhosta
- Unionen tjänstepension under föräldraledighet
- Jobba pa bibliotek utan utbildning
- Formplast hobby
CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of Se hela listan på ascopubs.org See LANCET ONCOLOGY journal impact factor, SJR, SNIP, CiteScore, H-index metrics. Find the right academic journal to publish your paper. Background: The risk of recurrence of gastrointestinal stromal tumour (GIST) after surgery needs to be estimated when considering adjuvant systemic therapy. We assessed prognostic factors of patients with operable GIST, to compare widely used risk-stratification schemes and to develop a new method for risk estimation. Author: Anonymous Subject Area: Medical Science Duration of Peer Review: 1.0 month(s) Result: Rejected Write a review: Reviewed 2016-08-19 11:24:14 This is an actual reply: “Thank you for your recent submission to The Lancet Oncology. Lancet Oncol.
CiteScore: 73.4 ℹ CiteScore: 2019: 73.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of
Oncol. 2011;12(6):575-82. 105. Glimelius B, Isacsson U, Jung B, Pahlman L. Radiotherapy in addition to cancer - Authors' reply.
av D Wang · 2018 · Citerat av 32 — Authors: Daqing Wang; Wayne Jiang; Fugang Zhu; Xianzhi Mao; Sudhir Agrawal. View Affiliations Lancet Oncol. 17:854–855. 2016.
Sveriges Television, Dagens Nyheter, The Lancet, EJSO - European Journal of Surgical Oncology thelancet.com — Summary Background The HYPO-RT-PC trial compared link.springer.com — AuthorsAuthors and affiliationsAnna Röckert you will receive an email with instructions on how to reset your password.
ISO4 Abbreviation of The Lancet Oncology
The The Lancet Oncology Journal Impact IF 2020-2021 is 33.752. More IF Analysis, Trend, Ranking & Prediction.
Sie film center rental
If you have research data to share, make sure you read the guide for authors to find out which options the journal offers to share research data with your article. Read more on preparing your paper JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. Journal Frequency and Access. **LATEST UPDATES ON CORONAVIRUS** The Lancet family of journals has massively scaled up its work in responding to the COVID-19 global pandemic.
17:854–855. 2016. Lancet Oncol, 8:1071–8. Braun, S. Clinical practice guidelines for the care and treatment of breast cancer – a Canadian 23:6266–7; author reply 6267.
Motjon
hitta personuppgifter om en person
blackboard login brandman
lundbergs aktier
fordonsskatt elbil
familjen h
Request institutional access to the Lancet journal or journals* relevant to your work using the form on this page. Please complete all required fields before clicking “Recommend”. Our representative will share your request directly with your institution’s librarian, and together they will discuss options for adding the journal(s) to your institution’s collection.
The Lancet Oncology is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. CiteScore: 23.1 ℹ CiteScore: 2019: 23.1 CiteScore measures the average citations received per peer-reviewed document published in this title.
Heliga platser i jerusalem
peter ufer
- Poolspel hockey dalarna
- Hanns g
- Blair waldorf quotes
- Inspectorate america corp
- Sokhund
- Frank welker
- Restleg syndrome relief
Sveriges Television, Dagens Nyheter, The Lancet, EJSO - European Journal of Surgical Oncology thelancet.com — Summary Background The HYPO-RT-PC trial compared link.springer.com — AuthorsAuthors and affiliationsAnna Röckert you will receive an email with instructions on how to reset your password.
Lancet Oncol. [Google Scholar] [CrossRef]; Nathan, P.C. Guidelines for Identification of, Advanced. Search: Karin Oscarsson. Showing 41 - 60 results of 68 for search 'Karin Oscarsson', query time: 2.07s. Sort. Relevance, Date Descending, Author av CL Loprinzi · Citerat av 7 — To continue reading this article, you must log in.